Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the ...

Novo Nordisk, a leading global pharmaceutical company, is investing $4.1 billion to build a second fill and finishing manufacturing site in Clayton, North Carolina, creating 1,000 new jobs in ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is primarily manufactured in Denmark, although Novo Nordisk has some manufacturing capacity in Clayton, North Carolina. It's likely ...

Novo Nordisk has been manufacturing some active pharmaceutical ingredients, and finished products, in the US, and is investing further, with a $4.1bn factory in North Carolina announced last year.

although Novo Nordisk has some manufacturing capacity in Clayton, North Carolina. It's likely, therefore, that steep tariffs on products imported to the U.S. from Denmark would cause the prices of ...

Eli Lilly has invested $5.3 billion to expand manufacturing capacity, while Novo Nordisk is building a $4.1 billion fill-finish plant in Clayton, North Carolina. However, these expansions take ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human therapeutics, will collaborate with Novo Nordisk A/S to co ... for research ...